PPM1A
Basic information
Region (hg38): 14:60245752-60299087
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPM1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 0 |
Variants in PPM1A
This is a list of pathogenic ClinVar variants found in the PPM1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-60282686-C-G | not specified | Uncertain significance (Dec 15, 2023) | ||
14-60282753-G-A | not specified | Uncertain significance (May 09, 2023) | ||
14-60282771-G-A | not specified | Uncertain significance (May 04, 2022) | ||
14-60282774-A-T | not specified | Uncertain significance (Aug 04, 2023) | ||
14-60282858-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
14-60282940-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
14-60283024-G-T | not specified | Uncertain significance (Nov 11, 2024) | ||
14-60283044-T-C | not specified | Uncertain significance (Jan 08, 2024) | ||
14-60283094-G-A | not specified | Uncertain significance (Aug 26, 2024) | ||
14-60283166-A-G | not specified | Uncertain significance (Jul 17, 2024) | ||
14-60283168-G-C | not specified | Uncertain significance (Apr 25, 2022) | ||
14-60283230-A-G | not specified | Uncertain significance (Nov 07, 2024) | ||
14-60283326-A-G | not specified | Uncertain significance (Feb 11, 2022) | ||
14-60283390-A-T | not specified | Uncertain significance (Dec 13, 2021) | ||
14-60283391-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
14-60283391-G-T | not specified | Uncertain significance (Aug 14, 2024) | ||
14-60283488-A-G | not specified | Uncertain significance (Aug 26, 2022) | ||
14-60283489-T-G | not specified | Uncertain significance (Dec 10, 2024) | ||
14-60285682-C-T | not specified | Uncertain significance (May 26, 2022) | ||
14-60285710-G-T | not specified | Uncertain significance (Sep 27, 2021) | ||
14-60285731-C-G | not specified | Uncertain significance (Jun 28, 2022) | ||
14-60291404-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
14-60291416-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
14-60291449-G-A | not specified | Uncertain significance (Nov 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPM1A | protein_coding | protein_coding | ENST00000325642 | 6 | 53336 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00166 | 124833 | 0 | 1 | 124834 | 0.00000401 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.58 | 127 | 239 | 0.531 | 0.0000119 | 3023 |
Missense in Polyphen | 6 | 81.403 | 0.073708 | 1011 | ||
Synonymous | 0.418 | 80 | 84.9 | 0.942 | 0.00000448 | 816 |
Loss of Function | 4.00 | 0 | 18.7 | 0.00 | 0.00000103 | 258 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000883 | 0.00000883 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Enzyme with a broad specificity. Negatively regulates TGF-beta signaling through dephosphorylating SMAD2 and SMAD3, resulting in their dissociation from SMAD4, nuclear export of the SMADs and termination of the TGF-beta-mediated signaling. Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);TGF-Ncore;TGF-beta Signaling Pathway;MAPK Signaling Pathway;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Energy dependent regulation of mTOR by LKB1-AMPK;mTOR signalling;Downregulation of SMAD2/3:SMAD4 transcriptional activity;TGF_beta_Receptor;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;BMP receptor signaling;Signaling by TGF-beta Receptor Complex;Signaling by TGF-beta family members;Regulation of cytoplasmic and nuclear SMAD2/3 signaling
(Consensus)
Recessive Scores
- pRec
- 0.240
Intolerance Scores
- loftool
- 0.288
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- 0.994
- hipred
- Y
- hipred_score
- 0.794
- ghis
- 0.646
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppm1a
- Phenotype
- hearing/vestibular/ear phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;protein dephosphorylation;N-terminal protein myristoylation;cell cycle arrest;negative regulation of SMAD protein complex assembly;dephosphorylation;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;peptidyl-threonine dephosphorylation;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of transcription, DNA-templated;positive regulation of protein export from nucleus;cellular response to transforming growth factor beta stimulus;positive regulation of canonical Wnt signaling pathway;negative regulation of NIK/NF-kappaB signaling
- Cellular component
- nucleus;nucleoplasm;cytosol;plasma membrane;membrane
- Molecular function
- magnesium ion binding;protein serine/threonine phosphatase activity;magnesium-dependent protein serine/threonine phosphatase activity;protein binding;manganese ion binding;calmodulin-dependent protein phosphatase activity;R-SMAD binding